5 Stocks Raising The Health Services Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 21 points (0.1%) at 16,093 as of Tuesday, Nov. 26, 2013, 11:45 AM ET. The NYSE advances/declines ratio sits at 1,560 issues advancing vs. 1,331 declining with 131 unchanged.

The Health Services industry currently sits up 0.5% versus the S&P 500, which is up 0.1%. Top gainers within the industry include Fresenius Medical Care AG & Co. KGaA ( FMS), up 1.4%, and Agilent Technologies ( A), up 1.1%. On the negative front, top decliners within the industry include ResMed ( RMD), down 2.2%, and Waters Corporation ( WAT), down 1.4%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. Opko Health ( OPK) is one of the companies pushing the Health Services industry higher today. As of noon trading, Opko Health is up $0.28 (2.8%) to $10.20 on light volume. Thus far, 1.5 million shares of Opko Health exchanged hands as compared to its average daily volume of 5.1 million shares. The stock has ranged in price between $9.89-$10.29 after having opened the day at $10.00 as compared to the previous trading day's close of $9.92.

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Opko Health has a market cap of $4.1 billion and is part of the health care sector. Shares are up 107.7% year to date as of the close of trading on Monday. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and weak operating cash flow. Get the full Opko Health Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Covidien ( COV) is up $1.20 (1.8%) to $68.25 on average volume. Thus far, 931,185 shares of Covidien exchanged hands as compared to its average daily volume of 2.1 million shares. The stock has ranged in price between $67.20-$68.31 after having opened the day at $67.34 as compared to the previous trading day's close of $67.05.

Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. Covidien has a market cap of $30.3 billion and is part of the health care sector. The company has a P/E ratio of 19.7, above the S&P 500 P/E ratio of 17.7. Shares are up 15.8% year to date as of the close of trading on Monday. Currently there are 14 analysts that rate Covidien a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Covidien as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Covidien Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, HCA Holdings ( HCA) is up $1.19 (2.7%) to $45.54 on light volume. Thus far, 1.1 million shares of HCA Holdings exchanged hands as compared to its average daily volume of 3.6 million shares. The stock has ranged in price between $44.16-$45.57 after having opened the day at $44.40 as compared to the previous trading day's close of $44.35.

HCA Holdings, Inc., through its subsidiaries, provides health care services in the United States. HCA Holdings has a market cap of $20.0 billion and is part of the health care sector. The company has a P/E ratio of 14.3, below the S&P 500 P/E ratio of 17.7. Shares are up 48.4% year to date as of the close of trading on Monday. Currently there are 15 analysts that rate HCA Holdings a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates HCA Holdings as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share and poor profit margins. Get the full HCA Holdings Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Express Scripts ( ESRX) is up $0.77 (1.2%) to $67.41 on average volume. Thus far, 1.9 million shares of Express Scripts exchanged hands as compared to its average daily volume of 5.1 million shares. The stock has ranged in price between $66.35-$67.66 after having opened the day at $66.50 as compared to the previous trading day's close of $66.64.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $53.5 billion and is part of the health care sector. The company has a P/E ratio of 28.7, above the S&P 500 P/E ratio of 17.7. Shares are up 22.9% year to date as of the close of trading on Monday. Currently there are 13 analysts that rate Express Scripts a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year and growth in earnings per share. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Express Scripts Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, UnitedHealth Group ( UNH) is up $0.68 (0.9%) to $74.75 on light volume. Thus far, 1.7 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 5.1 million shares. The stock has ranged in price between $74.05-$74.99 after having opened the day at $74.21 as compared to the previous trading day's close of $74.07.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $74.2 billion and is part of the health care sector. The company has a P/E ratio of 13.9, below the S&P 500 P/E ratio of 17.7. Shares are up 36.0% year to date as of the close of trading on Monday. Currently there are 13 analysts that rate UnitedHealth Group a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, attractive valuation levels, good cash flow from operations and growth in earnings per share. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full UnitedHealth Group Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null